Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Bleeding disorder of unknown cause: an illustrated review on current practice, knowledge gaps, and future perspectives.
Monard ALL, Mussert CMA, van Duijl TT, Kruip MJHA, Henskens YMC, van den Biggelaar M, Schutgens REG, Schols SEM, Fijnvandraat KJ, Meijer K, den Exter PL, Nieuwenhuizen L, van Moort I, Baker RI, O'Donnell JS, Cnossen MH, Heubel-Moenen FCJI. Monard ALL, et al. Among authors: nieuwenhuizen l. Res Pract Thromb Haemost. 2024 Nov 13;8(8):102625. doi: 10.1016/j.rpth.2024.102625. eCollection 2024 Nov. Res Pract Thromb Haemost. 2024. PMID: 39687924 Free PMC article.
Predictive performance of pharmacokinetic-guided prophylactic dosing of factor concentrates in hemophilia A and B.
Goedhart TMHJ, Bukkems LH, Zwagemaker AF, Coppens M, Fijnvandraat K, Schols SEM, Schutgens REG, Eikenboom J, Heubel-Moenen FCJI, Ypma PF, Nieuwenhuizen L, Meijer K, Leebeek FWG, Mathôt RAA, Cnossen MH. Goedhart TMHJ, et al. Among authors: nieuwenhuizen l. Res Pract Thromb Haemost. 2024 Mar 28;8(3):102397. doi: 10.1016/j.rpth.2024.102397. eCollection 2024 Mar. Res Pract Thromb Haemost. 2024. PMID: 38689619 Free PMC article.
Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study.
Willems SPE, Simons A, Saes JL, Weiss M, Rijpma S, Schoormans S, Meijer K, Cnossen MH, Schutgens REG, van Es N, Nieuwenhuizen L, den Exter PL, Kruis IC, Blijlevens NMA, van Heerde WL, Schols SEM. Willems SPE, et al. Among authors: nieuwenhuizen l. Res Pract Thromb Haemost. 2024 Jun 17;8(4):102477. doi: 10.1016/j.rpth.2024.102477. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 39076726 Free PMC article.
Enhanced thrombin and plasmin generation profiles in alpha-2-antiplasmin-deficient patients: Data from the Rare Bleeding disorders in the Netherlands study.
Haisma B, Rijpma SR, Cnossen MH, den Exter PL, Kruis IC, Meijer K, Nieuwenhuizen L, van Es N, Schutgens REG, Blijlevens NMA, van Heerde WL, Schols SEM. Haisma B, et al. Among authors: nieuwenhuizen l. Res Pract Thromb Haemost. 2024 Oct 23;8(7):102604. doi: 10.1016/j.rpth.2024.102604. eCollection 2024 Oct. Res Pract Thromb Haemost. 2024. PMID: 39628652 Free PMC article.
von Willebrand Factor and Factor VIII Clearance in Perioperative Hemophilia A Patients.
van Moort I, Bukkems LH, Heijdra JM, Schutgens REG, Laros-van Gorkom BAP, Nieuwenhuizen L, van der Meer FJM, Fijnvandraat K, Ypma P, de Maat MPM, Leebeek FWG, Meijer K, Eikenboom J, Mathôt RAA, Cnossen MH; OPTI-CLOT Study Group. van Moort I, et al. Among authors: nieuwenhuizen l. Thromb Haemost. 2020 Jul;120(7):1056-1065. doi: 10.1055/s-0040-1710591. Epub 2020 Jun 1. Thromb Haemost. 2020. PMID: 32480417 Clinical Trial.
ADAMTS-13 and bleeding phenotype in von Willebrand disease.
Boender J, Nederlof A, Meijer K, Mauser-Bunschoten EP, Cnossen MH, Fijnvandraat K, van der Bom JG, de Meris J, Laros-van Gorkom BAP, van Galen KPM, Eikenboom J, de Maat MPM, Leebeek FWG; WiN Study Group. Boender J, et al. Res Pract Thromb Haemost. 2020 Oct 31;4(8):1331-1339. doi: 10.1002/rth2.12442. eCollection 2020 Nov. Res Pract Thromb Haemost. 2020. PMID: 33313472 Free PMC article.
Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders.
Atiq F, Saes JL, Punt MC, van Galen KPM, Schutgens REG, Meijer K, Cnossen MH, Laros-Van Gorkom BAP, Peters M, Nieuwenhuizen L, Kruip MJHA, de Meris J, van der Bom JG, van der Meer FJM, Fijnvandraat K, Kruis IC, van Heerde WL, Eikenboom HCJ, Leebeek FWG, Schols SEM; WiN, RBiN and TiN study groups. Atiq F, et al. Among authors: nieuwenhuizen l. EClinicalMedicine. 2021 Jan 29;32:100726. doi: 10.1016/j.eclinm.2021.100726. eCollection 2021 Feb. EClinicalMedicine. 2021. PMID: 33554093 Free PMC article.
Treatment of patients with rare bleeding disorders in the Netherlands: Real-life data from the RBiN study.
Maas DPMSM, Saes JL, Blijlevens NMA, Cnossen MH, den Exter PL, Kruis IC, Meijer K, Nieuwenhuizen L, Peters M, Schutgens REG, van Heerde WL, Schols SEM; RBiN study group. Maas DPMSM, et al. Among authors: nieuwenhuizen l. J Thromb Haemost. 2022 Apr;20(4):833-844. doi: 10.1111/jth.15652. Epub 2022 Feb 8. J Thromb Haemost. 2022. PMID: 35038781 Free PMC article.
Design of a Prospective Study on Pharmacokinetic-Guided Dosing of Prophylactic Factor Replacement in Hemophilia A and B (OPTI-CLOT TARGET Study).
Goedhart TMHJ, Bukkems LH, Coppens M, Fijnvandraat KJ, Schols SEM, Schutgens REG, Eikenboom J, Heubel-Moenen FCJI, Ypma PF, Nieuwenhuizen L, Meijer K, Leebeek FWG, Mathôt RAA, Cnossen MH. Goedhart TMHJ, et al. Among authors: nieuwenhuizen l. TH Open. 2022 Feb 3;6(1):e60-e69. doi: 10.1055/a-1760-0105. eCollection 2022 Jan. TH Open. 2022. PMID: 35280975 Free PMC article.
71 results